Narrowband UVB Phototherapy Underused for Pediatric Vitiligo

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 8, 2025.

By Lori Solomon HealthDay Reporter

TUESDAY, April 8, 2025 -- Narrowband UVB (nbUVB) phototherapy may be underutilized in pediatric vitiligo, according to a study published online March 18 in Pediatric Dermatology.

Kristin A. Tissera, from Massachusetts General Hospital in Boston, and colleagues evaluated nbUVB phototherapy in pediatric vitiligo through an online patient and caregiver survey to better understand patient experiences and barriers to care in this population.

Based on 111 survey responses, the researchers found that 51.4 percent were offered nbUVB and 45.1 percent used nbUVB for treatment of vitiligo before age 18 years. Not being offered nbUVB (36.1 percent), difficulty attending appointments (11.5 percent), and satisfaction with the current skin condition (11.5 percent) were the primary reasons for not pursuing nbUVB.

"Our results indicate high patient interest that outpaces the use rate of nbUVB in pediatric vitiligo," the authors write. "Almost half of respondents were not offered nbUVB. While this may reflect a lack of availability, feasibility, or access, further examination of physician perspectives regarding nbUVB may also be warranted. Addressing obstacles to access is crucial for improving treatment outcomes and quality of life."

Several authors disclosed ties to the pharmaceutical and biotechnology industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-09 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords